Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma

Journal of Neurochemistry

Volumn 76, Issue 5, 2001, Pages 1497-1508

  Abounader, R ^a   Ranganathan, S ^a   Kim, B Y S ^a   Nichols, C ^a   Laterra, J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

AP 1; c fos; c jun; Mitogen activated protein kinase; Phosphoinositide 3 kinase; Protein kinase C.

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; RAS PROTEIN; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TYROSINE KINASE RECEPTOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUROPROTECTION; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GLIOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-MET; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035089315     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00158.x     Document Type: Article

References (51)

1. Reversion of human glioblastoma malignancy by UlsnRNA/ribozyme targeting of scatter factor/hepatocyte frowth factor and c-met gene expression
2. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
3. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF
4. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
5. Scatter factor/hepatocyte growth factor activates AKT and protects against cytotoxic death in human glioblastoma via P13-kinase and AKT-dependent pathways
6. Mechanism of action of a dominant-negative mutant of c-Jun
7. Epidermal growth factor regulates the expression of its own receptor
8. Selective expression of the Met/HGF receptor in human central nervous system microglia
9. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength
10. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase
11. Hepatocyte growth factor/scatter factor stimulates wth Ras-guanine nucleotide exchanger
12. Ras activation in astrocytomas and neurofibromas
13. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
14. Primary response genes induced by growth factors and tumor promoters
15. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase
16. Hepatocyte growth factor/scatter factor Met signaling in tumorigenicity and invasion/metastasis
17. Activating mutations for the met tyrosine kinase receptor in human cancer
18. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain
19. Phosphoinositide 3-kinase induces scatering and tubulogenesis in epithelial cells through a novel pathway
20. Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines
21. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells
22. Scatter factor/hepatocyte growth factor gene transfer to 9L glioma cells enhances glioma growth and angiogenesis in vivo
23. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth
24. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells
25. The human hepatocyte growth factor receptor gene: Complete structural organization and promotrer characterization
26. Selective activation of phospholipase C gamma 1 and distinct protein kinase C subspecies in intracellular signaling by hepatocyte growth factor/scatter factor in primary cultured rat neocortical cells
27. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
28. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: Evidence for rapid decay of the 8 kb c-MET transcript
29. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas
30. Expression of c-met correlates with grade of malignancy in human astrocytic tumours: An immunohistochemical study
31. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
32. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
33. Suppression of various human tumor cell lines by a dominant negative H-ras mutant
34. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors
35. A multifunctional docking site mediates signalling and transformation by the HGF/SF receptor family
36. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly
37. Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WV-F344 rat liver stem-like cells
38. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells
39. Phosphatidylinositol-3-OH kinase as a direct target of Ras
40. Phosphatidylinositol 3′ kinase: One of the effectors of Ras
41. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase
42. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relationship to angiogenesis
43. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1
44. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering
45. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3
46. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
47. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf
48. Evidence for a role of Met'HGF/Sf during Ras-mediated tumorigenesis/metastasis
49. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
50. The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis